RELIVIA
Live / Applied — New application — not yet assigned to an examiner (as of 26 Feb 2026)
What this means for you
Not registered yet, but its 22 Dec 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79444792
- Mark type
- Stylized text
- Filed
- 22 Dec 2025
Goods and services
- Class 042 — Scientific and technological services: Providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for accessing, browsing and searching databases containing clinical research data in the field of cannabinoid-based pharmaceuticals and therapy; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for administering insurance coverage; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for customized searching and filtering of catalogs and formularies of the pharmaceutical products of others; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for managing insurance policies; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for processing insurance claims; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for providing information about cannabinoid-based pharmaceuticals and therapy; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for providing information about insurance policies and rates; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for searching structured and unstructured data for healthcare analytics; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for the management and electronic delivery of insurance documents and insurance claims information; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for use in customer relationship management (CRM); providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for use in the analysis and evaluation of the products of others to assure compliance with industry standards; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) to allow users to track and analyze consumer consumption of cannabinoid-based pharmaceuticals for medical purposes; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) to automate workflows in the field of healthcare; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for facilitating the interoperability and secure exchange of healthcare information; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for digital health analytics; cannabinoid product evaluation; data automation and collection of clinical data from pharmacy-led patient care programs to support evaluation, analysis, and research; data automation and data collection using software to evaluate, analyze, collect clinical research data in the field of cannabinoid-based pharmaceuticals and therapy; providing medical and scientific research information in the field of cannabinoid-based pharmaceuticals and therapy.
Owner
Prosecution history
- 26 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 26 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 26 Feb 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB